SCHEMBL8028062

SCHEMBL8028062

OC1=CCCC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8028662 0.83
SCHEMBL11045149 0.69
SCHEMBL1659298 0.69
SCHEMBL1339209 0.69
SCHEMBL17293223 0.69
SCHEMBL1340193 0.69
SCHEMBL1340501 0.69
SCHEMBL13458109 0.69
SCHEMBL1659670 0.69
SCHEMBL17293313 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110156628-B Cyclotriol derivative and preparation method and application thereof 暨南大学 2022-05-17 CN claimed
CN-110156628-B Cyclotriol derivative and preparation method and application thereof 暨南大学 2022-05-17 CN disclosed
US-11254653-B2 NLRP3 inflammasome inhibitors NOVARTIS AG (CH) 2022-02-22 US disclosed
US-20200361899-A1 NLRP3 INFLAMMASOME INHIBITORS NOVARTIS PHARMA AG (CH) 2020-11-19 US disclosed
EP-0982283-A2 Method for the separation of polyfunctional alcohols from water-soluble salts in aqueous systems Degussa-Hüls Aktiengesellschaft (DE) 2000-03-01 EP disclosed
US-4132726-A INTERMEDIATES FOR PROSTAGLANDIN COMPOUNDS TEIJIN LIMITED (JP) 1979-01-02 US disclosed